v3.26.1
Unaudited Condensed Statements of Changes in Shareholders’ Deficit - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Subscription Note Receivable
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Mar. 26, 2025
Balance (in Shares) at Mar. 26, 2025        
Net Income (Loss) (8,601) (8,601)
Balance at Mar. 31, 2025 (8,601) (8,601)
Balance (in Shares) at Mar. 31, 2025        
Balance at Mar. 26, 2025
Balance (in Shares) at Mar. 26, 2025        
Net Income (Loss)           (63,421)
Balance at Jun. 30, 2025 $ 654 24,346 (63,421) (38,421)
Balance (in Shares) at Jun. 30, 2025 6,543,103        
Balance at Mar. 31, 2025 (8,601) (8,601)
Balance (in Shares) at Mar. 31, 2025        
Issuance of Class B ordinary shares to Sponsor [1] $ 654 24,346 25,000
Underwriter purchased shares [1] 6,543,103        
Net Income (Loss) (54,820) (54,820)
Balance at Jun. 30, 2025 $ 654 24,346 (63,421) (38,421)
Balance (in Shares) at Jun. 30, 2025 6,543,103        
Balance at Dec. 31, 2025 $ 56 $ 654 (500,000) (2,303,752) (2,803,042)
Balance (in Shares) at Dec. 31, 2025 551,250 6,543,103        
Increase to deferred underwriting commissions due to exercise of over-allotment option [2] (675,000) (675,000)
Remeasurement of Class A ordinary shares to redemption value (1,519,942) (1,519,942)
Net Income (Loss) 1,286,495 1,286,495
Balance at Mar. 31, 2026 $ 56 $ 654 (500,000) (3,212,199) (3,711,489)
Balance (in Shares) at Mar. 31, 2026 551,250 6,543,103        
Balance at Dec. 31, 2025 $ 56 $ 654 (500,000) (2,303,752) (2,803,042)
Balance (in Shares) at Dec. 31, 2025 551,250 6,543,103        
Net Income (Loss)           2,185,631
Balance at Jun. 30, 2026 $ 56 $ 654 (500,000) (3,841,152) (4,340,442)
Balance (in Shares) at Jun. 30, 2026 551,250 6,543,103        
Balance at Mar. 31, 2026 $ 56 $ 654 (500,000) (3,212,199) (3,711,489)
Balance (in Shares) at Mar. 31, 2026 551,250 6,543,103        
Remeasurement of Class A ordinary shares to redemption value (1,528,089) (1,528,089)
Net Income (Loss) 899,136 899,136
Balance at Jun. 30, 2026 $ 56 $ 654 $ (500,000) $ (3,841,152) $ (4,340,442)
Balance (in Shares) at Jun. 30, 2026 551,250 6,543,103        
[1] Includes an aggregate of up to 853,448 Class B ordinary shares, $0.0001 par value subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (Note 6).
[2] As a result of the underwriters full exercise of the underwriters’ over-allotment option, the underwriters are entitled to additional deferred underwriting commissions of 3.0% from the gross proceeds from the sale of the additional 2,250,000 Units, or $675,000. As such, the Company recorded an adjustment of $675,000 to increase the deferred underwriting commission payable to $5,175,000. See Note 7.